Status:
COMPLETED
Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population
Lead Sponsor:
Cairo University
Collaborating Sponsors:
National Cancer Institute (NCI)
science and technology development fund, Egypt
Conditions:
Colorectal Neoplasms
Adenoma
Eligibility:
All Genders
18-85 years
Brief Summary
The incidence of colorectal cancer (CRC) is on the rise on a global scale. The number of cancer-related deaths related to CRC is also rising to an alarming level. This picture is similarly seen in Egy...
Eligibility Criteria
Inclusion
- Patients undergoing colonoscopy as part of their clinical care or part of screening program.
- Complete endoscopic examination (up to the caecum)
- Adequate colonic preparation
Exclusion
- \- Incomplete colonoscopic examination due to technical causes e.g. difficult colonoscopy, patient intolerance (N.B. a neoplastic mass causing lumen stenosis will not be excluded.)
- Poor colonic preparation obscuring adequate mucosal examination.
- Patients who have received any treatment for CRC and/or adenomas.
- Patients with known malignancy elsewhere (i.e. non-colorectal malignancy)
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
316 Patients enrolled
Trial Details
Trial ID
NCT01793207
Start Date
December 1 2012
End Date
March 1 2015
Last Update
May 6 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kar-Alaini hospital (Cairo Univeristy hospital)
Cairo, Egypt
2
National cancer institute
Cairo, Egypt